GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Erech Finance Cahalacha Ltd (XTAE:EFNC-M) » Definitions » 3-Year EBITDA Growth Rate

Erech Finance Cahalacha (XTAE:EFNC-M) 3-Year EBITDA Growth Rate : 0.00% (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Erech Finance Cahalacha 3-Year EBITDA Growth Rate?

Erech Finance Cahalacha's EBITDA per Share for the six months ended in Dec. 2024 was ₪-1.52.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Erech Finance Cahalacha was 88.70% per year. The lowest was -76.00% per year. And the median was -61.80% per year.


Competitive Comparison of Erech Finance Cahalacha's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Erech Finance Cahalacha's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Erech Finance Cahalacha's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Erech Finance Cahalacha's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Erech Finance Cahalacha's 3-Year EBITDA Growth Rate falls into.


;
;

Erech Finance Cahalacha 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Erech Finance Cahalacha  (XTAE:EFNC-M) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Erech Finance Cahalacha 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Erech Finance Cahalacha's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Erech Finance Cahalacha Business Description

Traded in Other Exchanges
N/A
Address
Yakov Eliav 5, Downtown, Jerusalem, ISR
Erech Finance Cahalacha Ltd, formerly Insuline Medical Ltd is a medical device company. It develops & markets technologies to the clinical effectiveness of devices & drugs for the treatment of diabetes. Its products include the InsuPatch device for insulin pump users, & the InsuPad device for injection users. The InsuPad is a company's flagship product.

Erech Finance Cahalacha Headlines

No Headlines